Publications of A. Schuld
All genres
Journal Article (63)
41.
Journal Article
73, pp. 243 - 247 (2001)
Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 42.
Journal Article
69, pp. 116 - 137 (2001)
Zur Pathophysiologie der Gewichtsregulation im Rahmen der Therapie mit Psychopharmaka. Fortschritte der Neurologie/Psychiatrie 43.
Journal Article
69 (Sonderh. 2), pp. S 65 - S 74 (2001)
Zur klinischen Relevanz der Wirkung von Clozapin auf die Freisetzung von Zytokinen und löslichen Zytokinrezeptoren. Fortschritte der Neurologie/Psychiatrie 44.
Journal Article
58, pp. 445 - 452 (2001)
Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry 45.
Journal Article
26, pp. 65 - 76 (2001)
Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients. Psychoneuroendocrinology 46.
Journal Article
2, pp. 53 - 55 (2001)
Narkolepsie. Für jedes Symptom das richtige Medikament. Urotransmitter 47.
Journal Article
12, pp. 694 - 698 (2000)
Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Cytokine 48.
Journal Article
917, pp. 488 - 499 (2000)
Experimental immunomodulation, sleep, and sleepiness in humans. Annals of the New York Academy of Sciences 49.
Journal Article
4, pp. 68 - 78 (2000)
Schlaf und Schläfrigkeit im Rahmen von Infektionen und im Rahmen experimenteller Immunmodulation beim Menschen. Somnologie 50.
Journal Article
20, pp. 579 - 580 (2000)
Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved? [Lett]. Journal of Clinical Psychopharmacology 51.
Journal Article
72, pp. 195 - 198 (2000)
Reduced leptin levels in human narcolepsy. Neuroendocrinology 52.
Journal Article
355, pp. 1274 - 1275 (2000)
Increased body-mass index in patients with narcolepsy [Lett]. Lancet 53.
Journal Article
43, pp. 159 - 166 (2000)
Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophrenia Research 54.
Journal Article
102, pp. 153 - 155 (2000)
Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Acta Psychiatrica Scandinavica 55.
Journal Article
33, pp. 109 - 111 (2000)
A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 56.
Journal Article
85, pp. 4624 - 4629 (2000)
Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. Journal of Clinical Endocrinology & Metabolism 57.
Journal Article
33, pp. 407 - 418 (1999)
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. Journal of Psychiatric Research 58.
Journal Article
156, pp. 312 - 314 (1999)
Body weight and leptin plasma levels during treatment with antipsychotic drugs. American Journal of Psychiatry 59.
Journal Article
19, pp. 478 - 479 (1999)
Periodic leg movements and restless legs syndrome probably caused by olanzapine. Journal of Clinical Psychopharmacology 60.
Journal Article
8, pp. 321 - 322 (1999)
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. Journal of Sleep Research